Peter Payne is a highly accomplished executive with over 30 years of leadership experience in the pharmaceutical, biotechnology, and contract research organization (CRO) industries. Known for his integrity and results-driven approach, Peter has successfully led organizations through periods of significant growth and transformation. With deep expertise in drug development, clinical trials, and corporate strategy, he has built a strong reputation for driving innovation and strategic partnerships. His leadership spans notable roles, including Vice President at Optum, President of Gennaker Bio, and CEO at multiple biotech companies. Peter’s ability to communicate complex strategies and foster cross-functional collaboration has made him a respected figure in the life sciences industry.

Quynh Ton is a dedicated and resilient molecular and cellular developmental biologist with over 10 years of experience in the biotech industry. Known for her integrity and commitment to improving patient care, Quynh combines her extensive knowledge in drug discovery, gene therapy, and antibody development with a proven track record in business development. She has successfully secured significant contracts, demonstrating her strategic acumen and ability to drive initiatives within her field. Quynh's exceptional communication skills enable her to convey complex scientific concepts clearly, fostering collaboration across diverse teams and stakeholders. Her passion for advancing scientific knowledge and delivering impactful solutions positions her as a valuable asset in any organization.